These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 7785120)
1. [The effect of a Rhodiola rosea extract on the incidence of recurrences of a superficial bladder cancer (experimental clinical research)]. Bocharova OA; Matveev BP; Baryshnikov AIu; Figurin KM; Serebriakova RV; Bodrova NB Urol Nefrol (Mosk); 1995; (2):46-7. PubMed ID: 7785120 [TBL] [Abstract][Full Text] [Related]
2. [Changes in the mechanical integration of transitional epithelial cells and in the immune status of patients with bladder tumors]. Bocharova OA; Serebriakova RV; Golubeva VA; Figurin KM; Bukharkin BV; Bodrova NB; Matveev BP; Baryshnikov AIu Urol Nefrol (Mosk); 1994; (3):27-30. PubMed ID: 8079407 [TBL] [Abstract][Full Text] [Related]
3. [International Consensus Panel--treatment strategies for superficial bladder cancer]. Adler S; St Niclas M Aktuelle Urol; 2006 Sep; 37(5):320-3; discussion 322-3. PubMed ID: 17004179 [No Abstract] [Full Text] [Related]
4. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis. Huncharek M; McGarry R; Kupelnick B Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841 [TBL] [Abstract][Full Text] [Related]
5. [Significance of random biopsies of healthy mucosa in superficial bladder tumor]. Fernández Gómez JM; Rodríguez Martínez JJ; Escaf Barmadah S; Pérez García J; García J; Casasola Chamorro J Arch Esp Urol; 2000 Nov; 53(9):785-97. PubMed ID: 11196385 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial. Goebell PJ; Otto T; Suhr J; Rübben H J Urol; 2002 Jul; 168(1):72-5. PubMed ID: 12050495 [TBL] [Abstract][Full Text] [Related]
7. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour. Solsona E; Iborra I; Rubio J; Casanova J; Almenar S BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101 [TBL] [Abstract][Full Text] [Related]
8. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations. Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315 [TBL] [Abstract][Full Text] [Related]
9. Neoadiuvant treatment with intravesical interleukin-2 for recurrent superficial transitional bladder carcinoma Ta-T1/G1-2. Grasso M; Torelli F; Scannapieco G; Franzoso F; Lania C J Immunother; 2001; 24(2):184-7. PubMed ID: 11265776 [TBL] [Abstract][Full Text] [Related]
10. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base. David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135 [TBL] [Abstract][Full Text] [Related]
11. [Characteristics of recurrence of T1G3 transitional cell carcinoma of bladder]. Zhang YS; Li HZ; Zhang RQ; Shi BB Zhonghua Yi Xue Za Zhi; 2006 May; 86(19):1305-8. PubMed ID: 16796897 [TBL] [Abstract][Full Text] [Related]
12. [A prospective and randomized study of the complete response, index of recurrences and progression in superficial bladder carcinoma treated with mitomycin C alone versus mitomycin C and BCG alternatively]. Gelabert-Mas A; Arango Toro O; Bielsa Gali O; Lladó Carbonell C Arch Esp Urol; 1993 Jun; 46(5):379-82. PubMed ID: 8342972 [TBL] [Abstract][Full Text] [Related]